Reproducibility of serial whole-brain MR Spectroscopic Imaging

NMR in Biomedicine

Volumn 23, Issue 3, 2010, Pages 251-256

  Maudsley, A A ^a   Domenig, C ^a   Sheriff, S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Intra subject reproducibility; Proton MR spectroscopic imaging

Indexed keywords

AUTOMATED PROCEDURES; BRAIN MR; BRAIN REGIONS; BRAIN VOLUME; COEFFICIENTS OF VARIANCES; INDUCED MAGNETIC FIELDS; INTRA-SUBJECT REPRODUCIBILITY; INVERSION RECOVERY; MEAN VALUES; MEDIAN VALUE; N-ACETYLASPARTATE; RATIO IMAGES; REPRODUCIBILITIES; RIGID REGISTRATION; SPATIAL DISTRIBUTION; SPECTROSCOPIC IMAGING; TIME POINTS; VOXEL-BASED ANALYSIS;

IMAGE SEGMENTATION; MAGNETIC FIELDS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; METABOLITES; PROTONS; SPIN POLARIZATION;

QUALITY CONTROL;

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN REGION; FEMALE; HUMAN; MAGNETIC FIELD; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REPRODUCIBILITY;

ADULT; ASPARTIC ACID; BRAIN; BRAIN MAPPING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; REPRODUCIBILITY OF RESULTS;

EID: 77949663361     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1445     Document Type: Article

References (32)

1. Nelson SJ, Vigneron DB, Dillon WP. Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI. NMR Biomed 1999; 12: 123-138.
2. Suhy J, Miller RG, Rule R, Schuff N, Licht J, Dronsky V, Gelinas D, Maudsley AA,WeinerMW. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology 2002; 58: 773-779.
3. Munoz Maniega S, Cvoro V, Chappell FM, Armitage PA, Marshall I, Bastin ME, Wardlaw JM. Changes in NAA and lactate following ischemic stroke: a serial MR spectroscopic imaging study. Neurology 2008; 71: 1993-1999.
4. Sajja BR, Narayana PA, Wolinsky JS, Ahn CW. Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study. Mult. Scler 2008; 14: 73-80.
5. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neurorep 1998; 9: 1757-1761.
6. Jang JH, Kwon JS, Jang DP, Moon WJ, Lee JM, Ha TH, Chung EC, Kim IY, Kim SI. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. Am. J. Psychiatry 2006; 163: 1202-1207.
7. Langer DL, Rakaric P, Kirilova A, Jaffray DA, Damyanovich AZ. Assessment of metabolite quantitation reproducibility in serial 3D-(1)H-MR spectroscopic imaging of human brain using stereotactic repositioning. Magn. Reson. Med. 2007; 58: 666-673.
8. Ratai EM, Hancu I, Blezek DJ, Turk KW, Halpern E, Gonzalez RG. Automatic repositioning of MRSI voxels in longitudinal studies: impact on reproducibility of metabolite concentration measurements. J. Magn. Reson. Imaging 2008; 27: 1188-1193.
9. Chard DT, McLean MA, Parker GJ, MacManus DG, Miller DH. Reproducibility of in vivo metabolite quanti.cation with proton magnetic resonance spectroscopic imaging. J. Magn. Reson. Imaging 2002; 15: 219-225.
10. Li BS, Babb JS, Soher BJ, Maudsley AA, Gonen O. Reproducibility of 3D proton spectroscopy in the human brain. Magn. Reson. Med. 2002; 47: 439-446.
11. Tedeschi G, Bertolino A, Campbell G, Barnett AS, Duyn JH, Jacob PK, Moonen CT, Alger JR, Di Chiro G. Reproducibility of proton MR spectroscopic imaging .ndings. AJNR Am. J. Neuroradiol 1996; 17: 1871-1879.
12. DeVito TJ, Nicolson Y, Bureau Y, Williamson PC, Drost DJ. Reproducibility of multi-slice 2D proton MRSI at 3.0T. International Society for Magnetic Resonance in Medicine Kyoto. 2004; 2459.
13. Gu M, Kim DH, Mayer D, Sullivan EV, Pfefferbaum A, Spielman DM. Reproducibility study of whole-brain 1H spectroscopic imaging with automated quanti.cation. Mag. Reson. Med. 2008; 60: 542-5547.
14. Simmons A, Smail M, Moore E, Williams SC. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain. Magn. Reson. Imaging 1998; 16: 319-330.
15. Wardlaw JM, Signorini DF, Marshall I. Re: erial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain Simmons et al. 1996, vol. 16, pages 319-330 1998. Magn. Reson. Imaging 1998; 17: 483-487.
16. Kreis R. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 2004; 17: 361-381.
17. Maudsley AA, Domenig C, Govind V, Darkazanli A, Studholme C, Arheart K, Bloomer C. Mapping of brain metabolite distributions by volumetric proton MR Spectroscopic Imaging (MRSI). Magn. Reson. Med. 2009; 61: 548-559.
18. Maudsley AA, Darkazanli A, Alger JR, Hall LO, Schuff N, Studholme C, Yu Y, Ebel A, Frew A, Goldgof D, Gu Y, Pagare R, Rousseau F, Sivasankaran K, Soher BJ, Weber P, Young K, Zhu X. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed 2006; 19: 492-503.
19. Ebel A, Maudsley AA. Improved spectral quality for 3D MR spectroscopic imaging using a high spatial resolution acquisition strategy. Magn. Reson. Imaging 2003; 21: 113-120.
20. Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis III: Application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn. Reson. Med. 1998; 40: 822-831.
21. Haupt CI, Schuff N, Weiner MW, Maudsley AA. Removal of lipid artifacts in 1H spectroscopic imaging by data extrapolation. Magn. Reson. Med. 1996; 35: 678-687.
22. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23 (Suppl 1): S208-219.
23. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 2001; 20: 45-57.
24. Collins DL, Zijdenbos AP, Kollokian V, Sled JG, Kabani NJ, Holmes CJ, Evans AC. Design and construction of a realistic digital brain phantom. IEEE Trans. Med. Imaging 1998; 17: 463-468.
25. Studholme C, Hill DL, Hawkes DJ. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med. Phys. 1997; 24: 25-35.
26. Rousseau F, Maudsley AA, Ebel A, Darkazanli A, Weber P, Sivasankaran K, Yu Y, Studholme C. Evaluation of sub-voxel registration accuracy between MRI and 3D MR spectroscopy of the brain. Proc. Soc. Photo. Opt. Instrum. Eng. San. Diego 2005; 1213-1221.
27. Poline JB, Worsley KJ, Evans AC, Friston KJ. Combining spatial extent and peak intensity to test for activations in functional imaging. Neuroimage 1997; 5: 83-96.
28. Marshall I, Wardlaw J, Cannon J, Slattery J, Sellar RJ. Reproducibility of metabolite peak areas in 1H MRS of brain [see comments]. Magn. Reson. Imaging 1996; 14: 281-292.
29. Marshall I, Wild J. A systematic study of the lactate lineshape in PRESS-localized proton spectroscopy. Magn Reson Med 1998; 40: 72-78.
30. Wellard RM, Briellmann RS, Jennings C, Jackson GD. Physiologic variability of single-voxel proton MR spectroscopic measurements at3T. AJNR Am. J. Neuroradiol 2005; 26: 585-590.
31. Ethofer T, Mader I, Seeger U, Helms G, Erb M, Grodd W, Ludolph A, Klose U. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn. Reson. Med. 2003; 50: 1296-1301.
32. Hanson LG, Adalsteinsson E, Pfefferbaum A, Spielman DM. Optimal voxel size for measuring global grey and white matter proton metabolite concentrations using chemical shift imaging. Magn. Reson. Med. 2000; 44: 10-18.